Protein Drug Delivery: Penetrating a Growth Market

Introduction

The protein therapeutic market is forecast to grow rapidly at a CAGR of 10.5% from 2003 to 2010, to almost double in value. The increased use, development and discovery of protein therapeutics will lead to increasing opportunities for drug delivery companies. Pharma companies need to utilize these technologies to gain a competitive edge in an increasingly crowded therapeutic protein market.

Scope

• Analysis of the protein therapeutics portfolio and pipeline for 50 leading pharma and biotech companies
• Benchmarking of the current and future protein drug delivery market by technology and therapeutic focus
• Evaluation of the key drivers and resistors of the protein drug delivery market
• Assessment of the strategic aims of pharmaceutical companies in utilizing protein drug delivery technologies

Highlights

The protein therapeutic market is largely immediate release, but there is a trend moving towards increased sustained release formulations. Datamonitor believes that pharmaceutical companies in the protein therapeutic market should look to in-license suitable technologies to improve the qualities and potential of their products.

The protein therapeutic market is primarily an injectable arena, but drug delivery companies are striving to develop non-injectable solutions to the delivery of protein therapeutics.

While the majority of protein therapeutics on the market do not have devices available, this is a growing segment of the market and Datamonitor expects the growth to accelerate. Datamonitor believes that companies should explore the use of devices to maximize the potential of their products and differentiate them from competitors.

Reasons to Purchase

• Identify the opportunities provided by current and future protein drug delivery technologies to effectively plan your product development
• Understand trends across technological and therapeutic fields to target resources effectively and recognize pipeline opportunities
• Optimize market penetration through improved knowledge of the growth drivers and corporate dynamics of the protein drug delivery market